SPY411.45-1.41 -0.34%
DIA337.53+0.74 0.22%
IXIC13,857.84-138.26 -0.99%

OncoCyte Corporation Common Stock Q4 EPS $(0.09) Beats $(0.11) Estimate, Sales $500.00K Miss $820.00K Estimate

OncoCyte Corporation Common Stock (AMEX:OCX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 40 percent increase over losses of $(0.15) per

· 03/16/2021 16:02
OncoCyte Corporation Common Stock (AMEX:OCX) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is a 40 percent increase over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $500.00 thousand which missed the analyst consensus estimate of $820.00 thousand by 39.02 percent.